Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
about
To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemmaTranscriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-GenomicsEndogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression?The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast CancerIdentification of Breast Cancer Prognosis Markers via Integrative AnalysisNon-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinomaThe G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancerCD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells.Mass spectrometry based strategy for studies of binding sites and structural changes of cisplatin binding to myoglobin.Influence of hypoxia-related genetic polymorphisms on the prognosis of patients with metastatic gastric cancer treated with EOF.Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxia.
P2860
Q26825809-36F107AD-1D3E-4614-8E73-B4AD76AEAEE8Q34694010-E9CCDC27-BCEB-4E88-8F79-165AB76C10B6Q35051171-755E50DA-A430-4768-BDFD-4C056912C367Q35604708-442B622A-4196-4EB7-BA07-FE89537957E5Q35838981-0C9165CF-4F78-49BE-A826-B70A8305F1D2Q36076435-B89BC78C-2D68-439C-90DE-5EF2A266712EQ37151107-56861CF6-E428-4570-8A34-8B502DF61B37Q37451956-B2E7C6B2-1977-414E-A942-8AF782BA7C2CQ39460924-C39D7E7F-AA8B-4D5F-A5DE-E061168FB51CQ39642324-455E1C13-856A-4BB9-89D9-55D392B4C687Q49076691-251A5182-BFAE-4B2D-93DF-7BE6FBF30214Q49334960-96B7F2AB-21B0-4B02-9B7E-6E860FEC875AQ51700948-0DDA7783-F793-4FCC-832F-43260A7D0108
P2860
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
@ast
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
@en
type
label
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
@ast
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
@en
prefLabel
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
@ast
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
@en
P2093
P2860
P356
P1476
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
@en
P2093
A-M Ladhoff
F R Fritzsche
G Kristiansen
J Gerhardt
J-P Theurillat
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605702
P407
P577
2010-06-01T00:00:00Z
P5875
P6179
1034971089